To order this detailed 260+ page report, please visit this link
Key Inclusions
§ A detailed review ofthe overall landscape of companies offering contract fill / finish services forprefilled syringes, along with analyses based on a number of relevantparameters, such as year of establishment, company size, scale of operation(preclinical, clinical and commercial), location of the headquarters, locationof fill / finish facilities, type of drug molecule (small molecule andbiologic), syringe barrel material (glass and plastic), syringe fill volume andadditional services offered (drug formulation, regulatory support, labellingand packaging, terminal sterilization, storage and logistics). In addition, thechapter includes details on prefilled syringe fill / finish installed capacityof the service providers.
§ Tabulated profiles ofkey players (shortlisted based on a proprietary criterion) across keygeographies, such as North America, Europe and Asia-Pacific. Each profileprovides an overview of the company, information on its overall service portfolio,fill / finish facilities, financial performance (if available), and details onrecent developments as well as an informed future outlook.
§ An analysis of therecent developments (since 2015) pertaining to contract fill / finish services,based on various parameters, such as year of development, type of activity /development (collaboration and expansions), scale of operation of the project,location of expanded facility, type of drug molecule involved and additionalservices offered.
§ An estimate of theglobal, contract fill / finish capacity of prefilled syringes, by taking intoconsideration the capacities of various fill / finish service providers (asavailable on respective company websites), collected via secondary and primaryresearch. The study examines the distribution of number of prefilled syringeunits and volume of drug filled, based on the company size of manufacturer(small-sized, mid-sized and large), scale of operation (preclinical / clinicaland commercial), location of headquarters and fill / finish facilities (NorthAmerica, Europe and Asia-Pacific) and type of drug molecule (small molecule andbiologics).
§ An informed estimateof the annual demand for fill / finish of prefilled syringes (in number ofunits), taking into account the marketed drugs available in prefilled syringesand other relevant parameters, such as target patient population, dosingfrequency and dose strength. The study provides the distribution of the annualdemand, based on the geography (North America (US), Europe (UK, France, Italy,Spain, Germany and rest of Europe), Latin America (Brazil, Mexico, Argentinaand rest of Latin America), Asia-Pacific (Japan, China, India, South Korea andrest of Asia-Pacific), and the Middle East and Africa (Saudi Arabia, UAE,Africa and rest of the Middle East)), type of drug molecule (small molecule andbiologics), therapeutic area (blood disorders, infectious diseases, metabolicdisorders, oncological disorders and others), syringe barrel material (glassand plastic) and number of barrel chambers (single chamber and dual chamber).
§ A detailed demand andsupply assessment of geographies, based on a number of parameters, such as thenumber of prefilled syringe combination product developers, number of prefilledsyringe manufacturers, number of prefilled syringe fill / finish serviceproviders, number of prefilled syringe fill / finish facilities, capacity anddemand for prefilled syringes in that particular geographical region.
§ An analysispresenting potential strategic partners (primarily drug developers) forprefilled syringe fill / finish service providers, based on differentparameters, such as developer strength, pipeline strength, type of drugmolecule, target therapeutic area and location of the headquarters of thecompany.
§ A discussion on thepotential growth areas, such as growing injectable drugs pipeline, increasingpopularity of prefilled syringes, rise in preference for outsourcing of fill / finish operations,technological advancements in aseptic fill / finish processes, and growingopportunities in the Asia-Pacific region.
§ A review of thelandscape of prefilled syringe manufacturers, featuring a list of key prefilledsyringes and their manufacturers, analyzed based on a number of relevantparameters, such as syringe barrel material (glass and plastic), number ofbarrel chambers (single chamber and dual chamber), type of needle system (fixedneedle system, luer lock and luer cone) barrel volume, year of establishmentand location of the headquarters of manufacturers.
The report also features the likelydistribution of the current and forecasted opportunity across important marketsegments, mentioned below:
- Scale of Operation
§ Preclinical / Clinical
§ Commercial
- Type of drug molecule
§ Biologic
§ Small Molecule
- Target therapeutic area
§ Blood disorders
§ Infectious diseases
§ Metabolic disorders
§ Oncological disorders
§ Neurological disorders
§ Autoimmune disorders
§ Others
- Syringe barrel material
§ Glass
§ Plastic
- Number of barrel chambers
§ Single chamber
§ Dual chamber
- Key Geographical Regions
§ North America
§ Europe
§ Latin America
§ Asia-Pacific
§ Middle East and Africa
To request sample pages, please visit this link
Key Questions Answered
§ Who are the key players offering fill / finish in prefilledsyringes, across the globe?
§ Whatis the current, installed capacity for fill / finish in prefilled syringes?
§ What is the annual, demand for prefilled syringes, at both clinicaland commercial scales?
§ Whatare the key geographical hubs of fill / finish services for prefilled syringes?
§ Whatare the key growth drivers within this domain?
§ How is the current and future market opportunity likely tobe distributed across key market segments?
You may also be interested in the following titles:
1. Prefilled SyringesMarket (5th Edition), 2020-2030
2. Biologics Fill /Finish Services Market, 2019-2030
Contact Us
Gaurav Chaudhary
+1 (415) 800 3415
